Limitations, agreements, and source contact

Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001 · Source last updated 2024-04-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

GT60

restrictive Agreement

true

point Of Contact

email

kkd.clintrial.82@kyowakirin.com

organization

Kyowa Kirin Pharmaceutical Development

phone

609-919-1100

title

Kyowa Kirin Pharmaceutical Development

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice